132 related articles for article (PubMed ID: 8271955)
1. Cellular receptor for urokinase-type plasminogen activator: function in cell-surface proteolysis.
Ellis V; Behrendt N; Danø K
Methods Enzymol; 1993; 223():223-33. PubMed ID: 8271955
[No Abstract] [Full Text] [Related]
2. The urokinase receptor: involvement in cell surface proteolysis and cancer invasion.
Ellis V; Pyke C; Eriksen J; Solberg H; Danø K
Ann N Y Acad Sci; 1992 Dec; 667():13-31. PubMed ID: 1339241
[No Abstract] [Full Text] [Related]
3. Specific inhibition of the activity of the urokinase receptor-mediated cell-surface plasminogen activation system by suramin.
Ellis V; Danø K
Biochem J; 1993 Dec; 296 ( Pt 2)(Pt 2):505-10. PubMed ID: 8257443
[TBL] [Abstract][Full Text] [Related]
4. Urokinase-dependent proteolysis in cultured colon cancer is directed by its receptor.
Hollas W; Boyd D
Semin Thromb Hemost; 1991 Jul; 17(3):225-30. PubMed ID: 1665585
[No Abstract] [Full Text] [Related]
5. Cellular receptor for urokinase-type plasminogen activator: protein structure.
Behrendt N; Ploug M; Rønne E; Høyer-Hansen G; Danø K
Methods Enzymol; 1993; 223():207-22. PubMed ID: 8271954
[No Abstract] [Full Text] [Related]
6. Receptor-mediated regulation of plasminogen activator function: plasminogen activation by two directly membrane-anchored forms of urokinase.
Vines DJ; Lee SW; Dichek DA; Ellis V
J Pept Sci; 2000 Sep; 6(9):432-9. PubMed ID: 11016879
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the binding of urokinase-type plasminogen activator (u-PA) to plasminogen, to plasminogen-activator inhibitor-1 and to the u-PA receptor.
Lijnen HR; De Cock F; Collen D
Eur J Biochem; 1994 Sep; 224(2):567-74. PubMed ID: 7925373
[TBL] [Abstract][Full Text] [Related]
8. Reply to comment on 'Effect of purified, soluble urokinase receptor on the plasminogen-prourokinase activation system' (A. A-R. Higazi).
Behrendt N; Danø K
FEBS Lett; 1997 Feb; 402(2-3):293-4. PubMed ID: 9037213
[No Abstract] [Full Text] [Related]
9. Differentiation-enhanced binding of the amino-terminal fragment of human urokinase plasminogen activator to a specific receptor on U937 monocytes.
Stoppelli MP; Corti A; Soffientini A; Cassani G; Blasi F; Assoian RK
Proc Natl Acad Sci U S A; 1985 Aug; 82(15):4939-43. PubMed ID: 2991901
[TBL] [Abstract][Full Text] [Related]
10. Pericellular proteolysis by leukocytes and tumor cells on substrates: focal activation and the role of urokinase-type plasminogen activator.
Kindzelskii AL; Amhad I; Keller D; Zhou MJ; Haugland RP; Garni-Wagner BA; Gyetko MR; Todd RF; Petty HR
Histochem Cell Biol; 2004 Apr; 121(4):299-310. PubMed ID: 15042374
[TBL] [Abstract][Full Text] [Related]
11. Cyclo19,31[D-Cys19]-uPA19-31 is a potent competitive antagonist of the interaction of urokinase-type plasminogen activator with its receptor (CD87).
Magdolen V; Bürgle M; de Prada NA; Schmiedeberg N; Riemer C; Schroeck F; Kellermann J; Degitz K; Wilhelm OG; Schmitt M; Kessler H
Biol Chem; 2001 Aug; 382(8):1197-205. PubMed ID: 11592401
[TBL] [Abstract][Full Text] [Related]
12. The receptor for urokinase-type plasminogen activator of a human keratinocyte line (HaCaT).
Reinartz J; Link J; Todd RF; Kramer MD
Exp Cell Res; 1994 Oct; 214(2):486-98. PubMed ID: 7925643
[TBL] [Abstract][Full Text] [Related]
13. Epidermal growth factor-binding protein activates soluble and receptor-bound single chain urokinase-type plasminogen activator.
Wolf BB; Brown MD
FEBS Lett; 1995 Dec; 376(3):177-80. PubMed ID: 7498536
[TBL] [Abstract][Full Text] [Related]
14. Plasminogen activation by receptor-bound urokinase.
Ellis V; Danø K
Semin Thromb Hemost; 1991 Jul; 17(3):194-200. PubMed ID: 1665584
[No Abstract] [Full Text] [Related]
15. Proteolytically active streptococcal pyrogenic exotoxin B cleaves monocytic cell urokinase receptor and releases an active fragment of the receptor from the cell surface.
Wolf BB; Gibson CA; Kapur V; Hussaini IM; Musser JM; Gonias SL
J Biol Chem; 1994 Dec; 269(48):30682-7. PubMed ID: 7982988
[TBL] [Abstract][Full Text] [Related]
16. The plasminogen system and cell surfaces: evidence for plasminogen and urokinase receptors on the same cell type.
Plow EF; Freaney DE; Plescia J; Miles LA
J Cell Biol; 1986 Dec; 103(6 Pt 1):2411-20. PubMed ID: 3023400
[TBL] [Abstract][Full Text] [Related]
17. A hybrid protein of urokinase growth-factor domain and plasminogen-activator inhibitor type 2 inhibits urokinase activity and binds to the urokinase receptor.
Ballance DJ; Marshall JM; Cottingham IR; Steven J; Berry SJ; Cederholm-Williams SA; Goodey AR; Courtney M
Eur J Biochem; 1992 Jul; 207(1):177-83. PubMed ID: 1321039
[TBL] [Abstract][Full Text] [Related]
18. Commentary on: 'Effect of purified soluble urokinase receptor on the plasminogen prourokinase activation system' by N. Behrendt and K. Dano, FEBS Letters, 393 (1996) 31-36.
Higazi AA
FEBS Lett; 1997 Feb; 402(2-3):291-2. PubMed ID: 9037212
[No Abstract] [Full Text] [Related]
19. Increased plasminogen binding is associated with metastatic breast cancer cells: differential expression of plasminogen binding proteins.
Ranson M; Andronicos NM; O'Mullane MJ; Baker MS
Br J Cancer; 1998 May; 77(10):1586-97. PubMed ID: 9635833
[TBL] [Abstract][Full Text] [Related]
20. Urokinase-catalyzed plasminogen activation at the monocyte/macrophage cell surface: a localized and regulated proteolytic system.
Vassalli JD; Wohlwend A; Belin D
Curr Top Microbiol Immunol; 1992; 181():65-86. PubMed ID: 1330446
[No Abstract] [Full Text] [Related]
[Next] [New Search]